Role of urologists in the era of new treatment modalities for CRPC in Japan - Abstract

New medical treatment modalities for castration resistant prostate cancer(CRPC), including hormonal therapy and chemotherapy, will be approved in Japan.

Here, we discuss the management of these new treatment strategies by urologists.

Written by:
Ozono S.   Are you the author?
Dept. of Urology, Hamamatsu University School of Medicine.

Reference: Gan To Kagaku Ryoho. 2014 Jul;41(7):823-6.


PubMed Abstract
PMID: 25131867

Article in Japanese.

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe